Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Calix Limited (CXL.AX)
Sydney, NSW, AU
Calix Limited, an Australian company established in Sydney in 2005, delivers industrial-scale solutions aimed at confronting worldwide sustainability concerns. Operating across Australia, Europe, the United States, and South East Asia, its product range is extensive. Offerings include ACTI-Mag, utilized for treating biogas and wastewater, and AQUA-Cal+, a water conditioner beneficial for shrimp aquaculture and revitalizing lakes. Its agricultural product, BOOSTER-Mag, is designed to boost crop yields, optimize fertilizer application, and manage insect pests and fungi. The company also pioneers LEILAC (low emissions intensity lime and cement) technology, assisting cement and lime producers in significantly cutting carbon dioxide emissions. Additionally, Calix provides sophisticated chemical dosing systems for wastewater purification, ensuring precise chemical introduction to stabilize pH levels, mitigate hydrogen sulphide odors, safeguard sewer infrastructure from corrosion, and extract unwanted components like phosphorus or fats, oils, and grease. Calix serves a diverse client portfolio spanning agriculture, aquaculture, cement and lime manufacturing, food and beverage, lake and pond restoration, marine coatings, wineries, water utilities, and the mining and mineral processing sectors.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.11% | -4.90% | -11.01% | -56.70% | -27.61% | -50.51% | +49.23% | -88.72% | -82.68% | -23.02% | -23.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+14.7% ★ Q4'25: +34.0% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+31.4% ★ Q4'25: -186.1% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-94.7% Q4'25: -81.5% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%-72.0% Q4'25: -74.7% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%-29.7% Q4'25: -123.7% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+9.9% Q4'25: +19.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-0.23× Q4'25: -0.16× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 2 Rev. Ana. 1 EPS Ana. |
Jun 2027 2 Rev. Ana. 1 EPS Ana. |
Jun 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.29M
est: 4.60M (-28.4%)
|
14.06M
est: 13.35M (+5.3%)
|
19.21M
est: 26.85M (-28.5%)
|
18.47M
est: 24.07M (-23.3%)
|
18.60M
est: 22.50M (-17.4%)
|
24.19M
est: 27.50M (-12.0%)
|
27.74M
est: 31.41M (-11.7%)
|
36.88M
36.30M – 37.45M
+17.4% YoY
|
45.58M
42.75M – 48.40M
+23.6% YoY
|
54.37M
54.37M – 54.37M
+19.3% YoY
|
| EBITDA |
-5.33M
est: -2.95M (-80.8%)
|
-4.21M
est: -8.55M (+50.7%)
|
-5.81M
est: -11.06M (+47.5%)
|
-12.69M
est: -14.26M (+11.0%)
|
-25.03M
est: -18.84M (-32.8%)
|
-19.52M
est: -24.22M (+19.4%)
|
-11.24M
est: -32.16M (+65.0%)
|
-23.61M
-23.98M – -23.24M
+26.6% YoY
|
-29.18M
-30.99M – -27.38M
-23.6% YoY
|
-34.81M
-34.81M – -34.81M
-19.3% YoY
|
| EBIT |
-7.17M
est: -3.77M (-90.0%)
|
-6.92M
est: -10.95M (+36.8%)
|
-9.00M
est: -9.97M (+9.8%)
|
-16.88M
est: -12.85M (-31.3%)
|
-23.17M
est: -16.98M (-36.4%)
|
-26.10M
est: -21.83M (-19.6%)
|
-19.98M
est: -27.91M (+28.4%)
|
-30.26M
-30.73M – -29.78M
-8.4% YoY
|
-37.40M
-39.71M – -35.08M
-23.6% YoY
|
-44.61M
-44.61M – -44.61M
-19.3% YoY
|
| Net Income |
-7.49M
est: -10.37M (+27.8%)
|
-7.08M
est: -2.92M (-142.0%)
|
-9.11M
est: -10.52M (+13.4%)
|
-16.34M
est: -13.55M (-20.6%)
|
-23.19M
est: -23.19M (+0.0%)
|
-25.26M
est: -25.26M (+0.0%)
|
-19.17M
est: -33.97M (+43.6%)
|
-16.43M
-16.70M – -16.16M
+51.6% YoY
|
-11.05M
-11.77M – -10.34M
+32.7% YoY
|
-9.68M
-10.20M – -9.17M
+12.4% YoY
|
| SGA |
5.13M
est: 3.78M (+35.9%)
|
7.89M
est: 10.96M (-28.0%)
|
10.47M
est: 11.72M (-10.7%)
|
12.89M
est: 15.11M (-14.7%)
|
17.15M
est: 19.96M (-14.1%)
|
25.68M
est: 25.66M (+0.1%)
|
24.37M
est: 25.79M (-5.5%)
|
30.27M
29.80M – 30.74M
+17.4% YoY
|
37.42M
35.10M – 39.73M
+23.6% YoY
|
44.63M
44.63M – 44.63M
+19.3% YoY
|
| EPS |
-0.06
est: -0.05 (-18.3%)
|
-0.05
est: -0.01 (-243.2%)
|
-0.06
est: -0.01 (-493.3%)
|
-0.10
est: -0.07 (-45.7%)
|
-0.13
est: -0.09 (-43.4%)
|
-0.14
est: -0.13 (-11.9%)
|
-0.10
est: -0.17 (+43.6%)
|
-0.08
-0.08 – -0.08
+51.6% YoY
|
-0.06
-0.06 – -0.05
+32.7% YoY
|
-0.05
-0.05 – -0.05
+12.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Philip Hargraves Hodgson | MD, Chief Executive Officer & Director | 504.0K | — |
| Mark Geoffrey Sceats | Co-Founder & Chief Scientist | 423.2K | — |
| Darren Charles FCPA | Chief Financial Officer & Company Secretary | 421.2K | male |
| Daniel Rennie | Chief Executive Officer of the LEILAC Group | 391.5K | male |
| Doug Kelley | GM of Water (North America) & President of Inland Environmental Resources, Inc. | 390.3K | — |
| Vincent Nguyen | General Manager of Operations | — | male |
| Helen Comerford | General Manager of People & Culture | — | female |
| Matt Boot-Handford | Chief Scientist of Calix Ventures | — | male |
| Vanessa Mayne | Sustainability Manager | — | female |
| Christineh Grigorian | Investor Relations Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CXL.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
